325441
Disparities in mortality across geographic scales in Texas
Data for this study were obtained from the Census Summary Files (SF) 2 and 4 for the year 2000, the Rural Health Research Center Rural-Urban Commuting Area Codes (RUCA), Texas Department of State Health Services Border and Public Health Region definitions, and Texas Vital Statistics for Multiple Causes of Death. Data were aggregated by public health regions, counties, and census tracts. Death counts were analyzed using hierarchical modeling controlling for individual level demographics and geographic level factors including poverty, ethnic density, proximity to the border, and rural-urban status, as well as visually using geographic information science (GIS).
Findings from thematic mapping indicate that non-Hispanic Whites have some of the highest rates of mortality for all causes across all levels. Non-Hispanic Blacks were largely at lower risk, overall, than non-Hispanic Whites, and Hispanics had the lowest rates across all groups. When using smaller-scale geospatial identifiers, results show greater variation in the needs and risk of different areas. This is especially true with census tracts where differences in rates can vacillate wildly in a small area.
Learning Areas:
EpidemiologyOther professions or practice related to public health
Public health or related public policy
Social and behavioral sciences
Learning Objectives:
Describe the application of geospatial epidemiology to examine differences in mortality across different geographic levels.
Compare differences in rates across geographic levels across racial/ethnic stratifiers.
Keyword(s): Mortality, Geographic Information Systems (GIS)
Qualified on the content I am responsible for because: I led the development and conduct in the research for this project including development of rates, mapping of rates, and the analyses for hierarchical linear modeling.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.